Medical Condition News

RSS

Pycnogenol counteracts kidney damage due to hypertension

An estimated one in ten adults suffers from kidney disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A leading cause of kidney disease is hypertension, which effects one out of every four U.S. adults. Chronically high blood pressure damages capillaries of the kidneys which in turn affects the organ's ability to filter waste and remove excess fluids from the body.

4 Mar 2010

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at risk for clinical outcomes than the commonly used measurement of fasting glucose, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Mar 2010

CureDuchenne: Scientific advisors to come together to find cure for DMD

Today, CureDuchenne, a nonprofit dedicated to raising funds and awareness for Duchenne Muscular Dystrophy (DMD), announced that on March 19, 2010 the organization’s scientific advisors from around the country will come together in the fight to find a cure for Duchenne Muscular Dystrophy.

4 Mar 2010

Researchers demonstrate the safety of potential vaccine against mesothelioma

Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses uses a patient's own dendritic cells (DC) with antigen from the patient's tumor, was able to induce a T-cell response against mesothelioma tumors.

4 Mar 2010

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.

4 Mar 2010

Gene therapy for LCA clears another hurdle: Study

Gene therapy for a severe inherited blindness, which produced dramatic improvements last year in 12 children and young adults who received the treatment in a clinical trial, has cleared another hurdle. The same research team that conducted the human trial now reports that a study in animals has shown that a second injection of genes into the opposite, previously untreated eye is safe and effective, with no signs of interference from unwanted immune reactions following the earlier injection.

4 Mar 2010

Cystoscopy: Cost-effective method of detecting tumors

In a new study from The University of Texas M. D. Anderson Cancer Center, researchers found that cystoscopy, the standard for screening for recurrence of early-stage bladder cancer, is a cost-effective method of detecting tumors.

4 Mar 2010

St. Jude Medical publishes clinical results of HOMEOSTASIS trial

St. Jude Medical, Inc. today announced publication of clinical results in the Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) trial.

4 Mar 2010

Belatacept drug can prevent graft rejection in kidney transplant recipients

The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.

4 Mar 2010

Failure of Alzheimer's drug Dimebon: Anavex Life Sciences comments

Anavex Life Sciences Corp. today issued a statement following today's announcement from Pfizer and Medivation (MDVN) that their investigational Alzheimer's drug Dimebon did not meet either its co-primary or secondary endpoints compared to placebo during pivotal Phase 3 clinical trials.

4 Mar 2010

MHAUS introduces new MH Mock Drill Training Kit to better prepare for MH emergencies

The Malignant Hyperthermia Association of the United States introduces a new MH Mock Drill Training Kit for Operating Room Staff to better prepare for MH emergencies

4 Mar 2010

Allergan, Bristol-Myers Squibb sign global exclusive license agreement for EHT/AGN 0001

ExonHit Therapeutics today reported the signing by Allergan, Inc. and Bristol-Myers Squibb Company of a global exclusive license agreement for the development and commercialization of EHT/AGN 0001 (AGN-209323), ExonHit’s lead compound from the most advanced program of its collaboration with Allergan.

4 Mar 2010

Pharmacists could be integral to the education and screening of people for osteoporosis, says researcher

University of Alberta researcher Nese Yuksel says pharmacists could be integral to the education and screening of people for osteoporosis, as pharmacists are easily accessible and are playing a greater role in health promotion and disease prevention.

4 Mar 2010

Biomoda and Amigenics collaborate to advance treatments for lung and other cancer

Biomoda, Inc. (www.biomoda.com) and Advanced Medical Imaging and Genetics (www.amigenics.com), an innovative medical clinic specializing in prevention and early detection of disease, announced their intent to collaborate on a variety of projects to advance technology for the early detection of lung and other cancer.

4 Mar 2010

Endocyte's PRECEDENT study: DSMB recommends enrollment to continue

Endocyte, Inc., a biotech company developing guided therapeutics and diagnostics for personalized medicine, has announced that an independent data safety monitoring board (DSMB) recommended that enrollment into the PRECEDENT study continue.

4 Mar 2010

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

A daily dose of vitamin D may just be what Chicagoans need to get through the long winter, according to researchers at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON). This nutrient lifts mood during cold weather months when days are short and more time is spent indoors.

4 Mar 2010

Women who participate in sorority rush display body dissatisfaction and eating disorder behaviors

Undergraduate women who join a sorority are more likely to judge their own bodies from an outsider's perspective (known as self-objectification) and display higher levels of bulimic attitudes and behaviors than those who do not take part in the sorority's recruitment process.

4 Mar 2010

Study: Salvage targeted therapy can be suitable for elderly patients with NSCLC

Research published in the March issue of the Journal of Thoracic Oncology sought to determine whether differences existed in tolerance and efficacy between patients age 70 and over and younger patients with non-small cell lung cancer (NSCLC) receiving salvage targeted therapy with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) or chemotherapy.

4 Mar 2010

Community support critical for reducing childhood obesity

Community support of school obesity prevention programs is critical to achieving a significant decrease in obesity among children, according to researchers at the Michael & Susan Dell Center for Advancement of Healthy Living, which is part of The University of Texas Health Science Center at Houston (UTHealth).

4 Mar 2010

Scientists identify two proteins that serve as biomarkers for tracking the spread of colon cancer

Scientists in China are reporting discovery of two proteins present in the blood of people with colon cancer that may serve as the potential biomarkers for accurately predicting whether the disease will spread. Their study is in ACS' Journal of Proteome Research, a monthly publication.

4 Mar 2010

Medical Condition News

Pycnogenol counteracts kidney damage due to hypertension

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

CureDuchenne: Scientific advisors to come together to find cure for DMD

Researchers demonstrate the safety of potential vaccine against mesothelioma

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

Gene therapy for LCA clears another hurdle: Study

Cystoscopy: Cost-effective method of detecting tumors

St. Jude Medical publishes clinical results of HOMEOSTASIS trial

Belatacept drug can prevent graft rejection in kidney transplant recipients

Failure of Alzheimer's drug Dimebon: Anavex Life Sciences comments

MHAUS introduces new MH Mock Drill Training Kit to better prepare for MH emergencies

Allergan, Bristol-Myers Squibb sign global exclusive license agreement for EHT/AGN 0001

Pharmacists could be integral to the education and screening of people for osteoporosis, says researcher

Biomoda and Amigenics collaborate to advance treatments for lung and other cancer

Endocyte's PRECEDENT study: DSMB recommends enrollment to continue

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

Women who participate in sorority rush display body dissatisfaction and eating disorder behaviors

Study: Salvage targeted therapy can be suitable for elderly patients with NSCLC

Community support critical for reducing childhood obesity

Scientists identify two proteins that serve as biomarkers for tracking the spread of colon cancer

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Latest News